Alterations of Chk1 and Chk2 expression in colon cancer

International Journal of Colorectal Disease

Volumn 23, Issue 12, 2008, Pages 1243-1249

  Stawinska, Magdalena ^a   Cygankiewicz, Adam ^a   Trzcinski, Radzislaw ^b   Mik, Michal ^b   Dziki, Adam ^b   Krajewska, Wanda M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chk1; Chk2; Colorectal cancer; Protein expression

Indexed keywords

CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PHOSPHOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 56749177163     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0551-8     Document Type: Article

References (42)

1. Bartek J, Falck J, Lukas J (2001) Chk2 kinase - a busy messenger. Nat Rev Mol Cell Biol 2:877-886
2. Motoyama N, Naka K (2004) DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Deve 14:11-16
3. Parrilla-Castellar ER, Arlander SJH, Karnitz L (2004) Dial 9-1-1 for DNA damage: The Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair 3:1009-1014
4. Xu X, Tsvetkov LM, Stern DF (2002) Chk2 activation and phosphorylation-dependent oligomerisation. Mol Cell Biol 22:4419-4432
5. Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13:738-747
6. Bartek J, Lukas J (2001) Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 490:117-122
7. Busby EC, Leistritz DS, Abraham RT, Karnitz LM, Sarkaria JN (2000) The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res 60:2108-2112
8. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ (2000) Chk1 is an essential kinase that is regulated by ATR and required for the G(2)/M DNA damage checkpoint. Genes Dev 14:1448-1459
9. Melo J, Toczynski D (2002) A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol 14:237-245
10. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ (1997) Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497-1501
11. Weiss RS, Matsuoka S, Elledge SJ, Leder P (2002) Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway. Curr Biol 12(1):73-77
12. Ahn J, Urist M, Prives C (2004) The Chk2 protein kinase. DNA Repair 3:1039-1047
13. Lee CH, Chung JH (2001) The hCds (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J Biol Chem 276:30537-30541
14. Ward IM, Wu X, Chen J (2001) Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J Biol Chem 276:47755-47758
15. Lukas J, Lukas C, Bartek J (2004) Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA Repair 3:997-1007
16. Seo GJ, Kim SE, Lee YM, Lee JR, Hahn MJ, Kim ST (2003) Determination of substrate specificity and putative substrates of Chk2 kinase. Biochem Biophys Res Commun 304:339-343
17. Walworth NC (2001) DNA damage: Chk1 and Cdc25, more than meets the eye. Curr Opin Genet Dev 11:78-82
18. Chen Y, Sanchez Y (2004) Chk1 in the DNA damage response: Conserved roles from yeasts to mammals. DNA Repair 3:1025-1032
19. Kalogeropoulos N, Christoforou Ch, Green AJ, Gill S, Ashcroft NR (2004) Chk-1 is an essential gene and is required for an S-M checkpoint during early embryogenesis. Cell Cycle 3:1196-1200
20. Stevens C, Smith L, La Thangue NB (2003) Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 5:401-409
21. Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Broggini M (1999) CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer 26:176-180
22. Menoyo A, Alazzouzi H, Espín E, Armengol M, Yamamoto H, Schwartz S (2001) Somatic Mutations in the DNA damage-response genes ATR and Chk1 in sporadic stomach tumors with microsatellite instability. Cancer Res 61:7727-7730
23. Reddy A, Yuille M, Sullivan A, Repellin C, Bell A, Tidy JA, Evans DJ, Farrell PJ, Gusterson B, Gasco M, Crook T (2002) Analysis of CHK2 in vulval neoplasia. Br J Cancer 86:756-760
24. Shigeishi H, Yokozaki H, Oue N, Kuniyasu H, Kondo T, Ishikawa T, Yasui W (2002) Increased expression of Chk2 in human gastric carcinomas harboring P53 mutations. Int J Cancer 99:58-62
25. Tort F, Hernandez S, Bea S, Martinez A, Esteller M, Herman JG, Puig X, Camacho E, Sanchez M, Nayach I, Lopez-Guillermo A, Fernandez PL, Colomer D, Hernandez L, Campo E (2002) CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas. Neoplasia 100:4602-4608
26. Vahteristo P, Tamminen A, Karvinen P, Eeorola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K, Nevanlinna H (2001) p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: Further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718-5722
27. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438
28. Kilpivaara O, Laiho P, Aaltonen LA, Nevanlinna H (2003) CHEK2 1100delC and colorectal cancer. J Med Genet 40:e110
29. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski T, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Złowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75(6):1131-1135
30. Weischer M, Bojesen SE, Tybjoerg-Hansen A, Axelsson CK, Nordestgaard BG (2006) Increased risk of breast cancer associated with CHEK2* 1100delC. J Clin Oncol 24:1-7
31. Cadman E, Bastwick IB, Eichberg I (1997) Determination of protein by a modified Lowry procedure in the presence of some commonly used detergents. Anal Biochem 96:21-23
32. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-688
33. Glass WF, Briggs RC, Hnilica LC (1981) Identification of tissue-specific nuclear antigens transferred to nitrocellulose from polyacrylamide gel. Science 211:70-72
34. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A 76:4350-4354
35. Lukas C, Bartkova J, Latella L, Falck J, Mailand N, Schroeder T, Sehested M, Lukas J, Bartek J (2001) DNA Damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res 61:4990-4993
36. Matsuoka S, Nakagawa T, Masuda A, Haruki N, Elledge SJ, Takahashi T (2001) Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer. Cancer Res 61:5362-5365
37. Semba S, Ouyang H, Han SY, Kato Y, Horii A (2000) Analysis of the candidate target genes for mutation in microsatellite instability-positive cancers of the colorectum, stomach and endometrium. Int J Oncol 16:731-737
38. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J (2001) Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene 20(41):5897-5902
39. Wu X, Webster SR, Chen J (2001) Characterization of tumor-associated Chk2 mutations. J Biol Chem 274:2971-2974
40. Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T (2003) Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene 21(9):1316-1324
41. Bartkova J, Hořejši Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870
42. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou L-VF, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Ørntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VS (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-637